Results

Total Results: 199 records

Showing results for "end stage renal".

  1. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
    July 06, 2015 - Inclusion and Exclusion Criteria from Original Systematic Review Citations at the abstract review stage … Articles could be excluded at this stage, in hierarchical order, for the following reasons: not a study … Abstracts from relevant literature are included at the end of the attached document. … Abstracts are provided for included literature at the end of the document. … =ejection fraction; CHD=coronary heart disease; RR=relative risk; CAD=coronary artery disease; ESRD=end-stage
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
    December 08, 2014 - ” or “extensive stage” disease with the following definitions: o Limited stage disease (LD): Cancer … o Extensive stage disease (ED): Cancer that cannot be classified as limited stage, such as when there … In addition, some patients cannot receive iodinated contrast material due to renal insufficiency, limiting … previously noted, performance of various imaging modalities may be impacted by comorbidities such renal … Because of their role as end-users, individuals are invited to serve as Key Informants and those who
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
    November 21, 2019 - - stage renal disease (on dialysis or choosing not to have dialysis and age 75 or older), and those with … These include advanced heart failure, advanced chronic obstructive pulmonary disease, end-stage renal … These include advanced heart failure, advanced chronic obstructive pulmonary disease, end-stage renal … Evidence for improving palliative care at the end of life: a systematic review. … Populations and Interventions for Palliative and End-of- Life Care: A Systematic Review.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
    March 01, 2013 - Two reviewers evaluated each study at the title or abstract stage and at the full text article stage … emergency room visits or hospitalizations for treatment of recurrent stones, quality of life, and end-stagerenal disease. … emergency room treatment and/or hospitalization related to stone recurrence, quality of life, and/or end-stagerenal disease.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
    October 08, 2014 - accounting for almost 60% of all organ transplants.1 Kidney transplantation is the treatment of choice for endstage renal disease. … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … graft dysfunction'/exp OR 'renal graft dysfunction' OR (kidney OR renal) NEAR/2 (allograft* OR alograft
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
    January 31, 2013 - shares similar risk factors: male gender, age, diabetes, smoking, hypertension, high cholesterol, and renal … Fontaine classification Stage I No symptoms Stage IIa Intermittent claudication > 200m of walking … Stage 3 Rest pain Stage 4 Necrosis/gangrene Table 2. … Rutherford classification Stage 0 Asymptomatic Stage 1 Mild claudication Stage 2 Moderate claudication … Stage 3 Severe claudication Stage 4 Rest pain Stage 5 Ischemic ulceration not exceeding ulcer of
  7. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
    June 01, 2015 -  High-Impact Potential: Lower end of the high-impact-potential range Gout Gout is the most prevalent …  High-Impact Potential: Lower end of the high-impact-potential range Psoriatic Arthritis Psoriatic …  High-Impact Potential: Lower end of the high-impact-potential range 1 Ankylosing Spondylitis … organic anion transporter involved in controlling the reabsorption of uric acid from the proximal renal … However, better gout management could reduce hospitalizations and renal or cardiovascular complications
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
    May 01, 2013 - race/ ethnicity, socioeconomic status, and diverse specific medical comorbidities (e.g., diabetes, end-stagerenal disease, dementia), many Key Informants suggested that we include specific known risk factors … race/ethnicity, socioeconomic status, and diverse specific medical comorbidities (e.g., diabetes, end-stagerenal disease, and dementia), as well as patients with specific known risk factors for pressure ulcers … Stage I is defined as superficial erythema, stage II as partial thickness ulceration, stage III as
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - Adjunct for the prevention of rejection in renal homotransplantation; management of active rheumatoid … (Hoffmann-La Roche) Prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac … Prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac, or hepatic transplants … Key Informants Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users, individuals are invited to serve as Key Informants and those who
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
    December 01, 2012 - To that end, advances in molecular and genomic medicine, such as gene expression profiling, may improve … underestimation of the tumor genomic landscape from analysis of multiple samples from patients with primary renal … 1) and stage D (Stage IV) colorectal cancer. … A or stage D. … T-stage, N-stage and MSI status.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
    February 01, 2011 - Those with diabetes are expected to suffer from several associ- ated medical complications, such as renal … The prevalence of LEA in nonelderly diabetics with PAD (many of whom likely have end-stage renal disease
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
    November 30, 2011 - harms differ according to patient subgroup characteristics, including HCV genotype, age, race, sex, stage … non-black); sex; stage of disease (e.g., cirrhosis or fibrosis); others (e.g., baseline viral load, … weight)  Exclusions: pregnant women, HIV co-infection, transplant recipients, and patients with renal … Key Informants Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users, individuals are invited to serve as Key Informants and those who
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
    January 01, 2011 - amputation 2 People with diabetes often experience sev- eral associated medical complications, such as renal … The latter set of ICD-9 codes represents the following microvascular diseases: diabetic renal disease … Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population.
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
    February 01, 2013 - No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically … RLS is unknown, but the disorder also occurs secondary to other conditions such as iron deficiency, end-stage … No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically excluded … - Stage Renal Disease Requiring Hemodialysis Drug: Rotigotine; Placebo NCT00258492 RLS Syndrome … Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole Drug: ropinirole dosing
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
    January 07, 2016 - On page 20 lines 5-13, this topic is finally broached at the end of the "Future Research" section. … We know that CIN incidence varies dramatically based on baseline renal function, and the absence of … contrast-induced nephropathy (CIN), for the outcomes of incidence of CIN, chronic kidney disease (CKD), endstage renal disease (ESRD), mortality, and other adverse events? … Need for renal replacement therapy is addressed in all comparisons.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
    March 15, 2016 - accepted the target serum uric acid (SUA) levels (as opposed to gout flare reduction) as their primary end-points … We have modified the text on use in renal impairment. … However, what is the stage before the acute arthritis stage? Asympotmatic hyperuricemia? … disease, and of intervening upon hyperuricemia demonstrating renal benefits. … These decisions were made at the Topic Refinement stage.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_technical-brief.pdf
    July 01, 2014 - Potential outcome measure by stage .................................................................. … Characteristics associated with ACP at various stages Stage of Health/Illness Healthy Potentially … domain: the interactive CD-ROM,32 the enhanced information aid,25 a Web site intervention in pilot stage … Potential outcome measure by stage Outcome Stage of Health / Illness Healthy Potentially Life Threatening … Paradigm Task Force Ottawa Patient Decision Aid Research Group PBS Religion & Ethics Newsweekly Renal
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendices.pdf
    January 01, 2025 - impairment, end-stage renal disease, urinary tract infection, stone-removal procedures/surgery, procedure … stone”[tw] OR “renal stones”[tw] OR “renal calcul*”[tw] OR  “staghorn calculi”[tw] OR “staghorn calculus … " NEXT stone):ti,ab OR ("renal" NEXT stones):ti,ab OR ("renal" NEXT calcul*):ti,ab OR ("staghorn" NEXT … J Endourol. 2020 Feb;34(2):139-44. doi: 10.1089/end.2019.0574. PMID: 31663371. … J Endourol. 2021 Dec;35(12):1844-51. doi: 10.1089/end.2021.0122. PMID: 34254834. 34.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
    January 01, 2025 - one of two locations: respiratory tract (lung and head/neck) and genitourinary (bladder, prostate, renal … enrichment was performed using the modified SureSelect Target Enrichment System for Illumina Paired End … sequencing library and enriched using standard hybridization capture conditions, for 150-bp paired-end … (NR) 0.927 (0.907 to 0.946) NA NA NA NA NA NA NA NA NA NA NA NA NA NA None Ren 2016 Diagnostic CC Renal … Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening:
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
    January 01, 2025 - one of two locations: respiratory tract (lung and head/neck) and genitourinary (bladder, prostate, renal … enrichment was performed using the modified SureSelect Target Enrichment System for Illumina Paired End … sequencing library and enriched using standard hybridization capture conditions, for 150-bp paired-end … (NR) 0.927 (0.907 to 0.946) NA NA NA NA NA NA NA NA NA NA NA NA NA NA None Ren 2016 Diagnostic CC Renal … Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: